Pro-Dex, Inc.

Equities

PDEX

US74265M2052

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 01:36:21 2024-07-12 pm EDT			5-day change	1st Jan Change
18.1 ^USD	+3.13%		+3.72%	+3.31%

May. 02	Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $14.3M	MT
May. 02	Earnings Flash (PDEX) PRO-DEX Posts Q3 EPS $0.19	MT

Tranche Update on Pro-Dex, Inc.'s Equity Buyback Plan announced on December 18, 2019.

May 02, 2024 at 04:01 pm EDT

From January 1, 2024 to March 31, 2024, the company has repurchased 90,605 shares, representing 2.56% for $1.72 million. With this, the company has completed the repurchase of 549,322 shares, representing 14.79% for $11.69 million under the buyback announced on December 18, 2019.

Latest news about Pro-Dex, Inc.

Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $14.3M	May. 02	MT
Earnings Flash (PDEX) PRO-DEX Posts Q3 EPS $0.19	May. 02	MT
Tranche Update on Pro-Dex, Inc.'s Equity Buyback Plan announced on December 18, 2019.	May. 02	CI
Pro-Dex, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 02	CI
Earnings Flash (PDEX) PRO-DEX Reports Q2 Revenue $12.6M	Feb. 08	MT
Tranche Update on Pro-Dex, Inc.'s Equity Buyback Plan announced on December 18, 2019.	Feb. 08	CI
Pro-Dex, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 08	CI
Pro-Dex, Inc. Enters into Amendment No. 3 to Amended and Restated Credit Agreement with Minnesota Bank and Trust	Jan. 03	CI
Earnings Flash (PDEX) PRO-DEX Reports Q1 Revenue $11.9M	Nov. 02	MT
Tranche Update on Pro-Dex, Inc.'s Equity Buyback Plan announced on December 18, 2019.	Nov. 02	CI
Pro-Dex, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 02	CI
North American Morning Briefing : Geopolitical -2-	23-10-18	DJ
Pro-Dex, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	23-10-13	CI
Tranche Update on Pro-Dex, Inc.'s Equity Buyback Plan announced on December 18, 2019.	23-10-13	CI
Pro-Dex, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-13	CI
North American Morning Briefing : Stock Futures -2-	23-10-11	DJ
North American Morning Briefing : S&P 500 Futures -2-	23-10-04	DJ
North American Morning Briefing : Stock Futures Helped by Retreating Bond Yields	23-09-27	DJ
North American Morning Briefing : Fed Seen Holding Rates, Powell Comments Key	23-09-20	DJ
North American Morning Briefing : Inflation -2-	23-09-06	DJ
North American Morning Briefing : Stock Futures -2-	23-08-30	DJ
North American Morning Briefing : Nvidia Results -2-	23-08-23	DJ
Earnings Flash (PDEX) PRO-DEX Reports Q3 Revenue $13.1M	23-05-04	MT
Earnings Flash (PDEX) PRO-DEX Reports Q3 EPS $0.36	23-05-04	MT
Tranche Update on Pro-Dex, Inc.'s Equity Buyback Plan announced on December 18, 2019.	23-05-04	CI

Chart Pro-Dex, Inc.

Duration

Period

More charts

Company Profile

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The Company has patented adaptive torque-limiting technology and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Companyâs medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It has an approximately 25,000 square foot industrial building in Tustin, California (the Franklin Property).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Pro-Dex, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.55 USD

Average target price

28 USD

Spread / Average Target

+59.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PRO-DEX, INC.	+3.31%	60.01M
ABBOTT LABORATORIES	-5.00%	181B
MEDTRONIC PLC	-5.09%	100B
BECTON, DICKINSON AND COMPANY	-5.72%	65.01B
HOYA CORPORATION	+16.45%	45.75B
DEXCOM, INC.	-7.58%	44.8B
CENCORA, INC.	+8.64%	43.72B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.72%	29.01B
TERUMO CORPORATION	+17.98%	26.03B
WEST PHARMACEUTICAL SERVICES, INC.	-7.09%	24.28B

Other Medical Equipment, Supplies & Distribution